ImmVira is a biotechnology company developing novel drug-delivery vector technologies, including oncolytic herpes simplex virus (oHSV) and exosome platforms
ImmVira is a biotechnology company developing novel drug-delivery vector technologies, including oncolytic herpes simplex virus (oHSV) and exosome platforms. It also develops viral-vector and exosome manufacturing capabilities, with GMP production infrastructure supporting clinical trials, co-development, commercialization, and commercial-scale manufacturing.